KPX Lifescience.Co.Ltd Free Cash Flow Generation Index

Latest as of September 2025: 0.92x

KPX Lifescience.Co.Ltd free cash flow generation index. KPX Lifescience.Co.Ltd (114450) has a Free Cash Flow Generation Index of 0.92x as of September 2025. Free cash flow of ₩3.05 Billion represents 1% of operating cash flow (₩3.33 Billion).

FCF Generation Index

0.92x
Free Cash Flow / Operating CF

Free Cash Flow

₩3.05 Billion
KRW

Operating Cash Flow

₩3.33 Billion
KRW

Capital Expenditures

₩275.98 Million
KRW

Free Cash Flow Generation Index of KPX Lifescience.Co.Ltd (2014–2024)

Free cash flow generation index of KPX Lifescience.Co.Ltd from 2014 to 2024. Historical FCF Generation Index trend for KPX Lifescience.Co.Ltd across 10 annual periods. See how financially flexible is KPX Lifescience.Co.Ltd to measure the company's free cash flow as a share of total liabilities.

KPX Lifescience.Co.Ltd Free Cash Flow Generation Index by Year (2014–2024)

KPX Lifescience.Co.Ltd free cash flow generation index by year from 2014 to 2024. Year-by-year Free Cash Flow Generation Index for KPX Lifescience.Co.Ltd. For the full cash flow conversion analysis, see cash flow conversion of KPX Lifescience.Co.Ltd.

Year FCG Index Free Cash Flow (KRW) Operating CF Capital Expenditures YoY Change
2024 0.12x ₩62.78 Million ₩525.49 Million ₩462.71 Million ▲ +142.1%
2023 -0.28x ₩-105.00 Million ₩370.02 Million ₩475.02 Million ▲ +93.9%
2021 -4.63x ₩-2.83 Billion ₩611.38 Million ₩3.44 Billion ▼ -1051.8%
2020 -0.40x ₩-765.10 Million ₩1.90 Billion ₩2.67 Billion ▼ -80.9%
2019 -0.22x ₩-943.30 Million ₩4.24 Billion ₩3.60 Billion ▼ -109.3%
2018 2.39x ₩12.87 Billion ₩5.38 Billion ₩7.49 Billion ▲ +36.1%
2017 1.76x ₩9.99 Billion ₩5.68 Billion ₩4.31 Billion ▲ +43.3%
2016 1.23x ₩8.67 Billion ₩7.07 Billion ₩1.60 Billion ▲ +12.2%
2015 1.09x ₩6.14 Billion ₩5.62 Billion ₩526.82 Million ▼ -9.3%
2014 1.21x ₩4.92 Billion ₩4.09 Billion ₩838.78 Million —
FCG Index = Free Cash Flow / Operating Cash Flow. FCF = Operating CF + Capital Expenditures (capex stored negative).